Congenital heart defects in molecularly confirmed KBG syndrome patients.


Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
04 2022
Historique:
revised: 30 10 2021
received: 05 06 2021
accepted: 11 12 2021
pubmed: 1 1 2022
medline: 19 4 2022
entrez: 31 12 2021
Statut: ppublish

Résumé

Congenital heart defects (CHDs) are known to occur in 9%-25% of patients with KBG syndrome. In this study we analyzed the prevalence and anatomic types of CHDs in 46 personal patients with KBG syndrome, carrying pathogenetic variants in ANKRD11 or 16q24.3 deletion, and reviewed CHDs in patients with molecular diagnosis of KBG syndrome from the literature. CHD was diagnosed in 15/40 (38%) patients with ANKRD11 variant, and in one patient with 16q24.3 deletion. Left ventricular outflow tract obstructions have been diagnosed in 9/15 (60%), subaortic or muscular ventricular septal defect in 5/15 (33%), dextrocardia in 1/15 (8%). The single patient with 16q24.3 deletion and CHD had complete atrioventricular septal defect (AVSD) with aortic coarctation. Review of KBG patients from the literature and present series showed that septal defects have been diagnosed in 44% (27/61) of the cases, left ventricular tract obstructions in 31% (19/61), AVSD in 18% (11/61). Septal defects have been diagnosed in 78% of total patients with 16q24.3 deletion. Valvar anomalies are frequently diagnosed, prevalently involving the left side of the heart. A distinctive association with AVSD is identifiable and could represent a marker to suggest the diagnosis in younger patients. In conclusion, after precise molecular diagnosis and systematic cardiological screening the prevalence of CHD in KBG syndrome seems to be higher than previously reported in clinical articles. In addition to septal defects, left-sided anomalies and AVSD should be considered. Clinical management of KBG syndrome should include accurate and detailed echocardiogram at time of diagnosis.

Identifiants

pubmed: 34971082
doi: 10.1002/ajmg.a.62632
doi:

Substances chimiques

Transcription Factors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1149-1159

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Botto, L. D., Lin, A. E., Riehle-Colarusso, T., Malik, S., & Correa, A. (2007). Seekung causes: Classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Research partA, 79, 714-727.
Brancati, F., D'Avanzo, M. G., Digilio, M. C., Sarkozy, A., Biondi, M., De Brasi, D., Mingarelli, R., & Dallapiccola, B. (2004). KBG syndrome in a cohort of Italian patients. American Journal Medical Genetics Part A, 131, 144-149.
Brancati, F., Sarkozy, A., & Dallapiccola, B. (2006). KBG syndrome. Orphanet Journal of Rare Diseases, 1, 50.
Crippa, M., Rusconi, D., Castronovo, C., Sestetti, I., Russo, S., Cereda, A., Selicorni, A., Larizza, L., & Finelli, P. (2015). Familial intragenic duplication of ANKRD11 underlying three patients of KBG syndrome. Molecular Cytogenetics, 8, 20.
David, D., Freixo, J. P., Fino, J., Carvalho, I., Marques, M., Cardoso, M., Piña-Aguilar, R. E., & Morton, C. C. (2020). Comprehensive clinically oriented workflow for nucleotide level resolution and interpretation in prenatal diagnosis of de novo apparently balanced chromosomal translocations in their genomic landscape. Human Genetics, 139, 531-543.
Devriendt, K., Holvoet, M., & Fryns, J. P. (1998). Further delineation of the KBG syndrome. Genetic Counseling, 9, 191-194.
Digilio, M. C., Marino, B., Giannotti, A., & Dallapiccola, B. (1994). Familial atrioventricular septal defect: Possibile genetic mechanism. British Heart Journal, 71, 79-81.
Digilio, M. C., Marino, B., Toscano, A., Giannotti, A., & Dallapiccola, B. (1999). Atrioventricular canal defect without Down syndrome: A heterogeneous malformation. American Journal Medical Genetics, 85, 140-146.
Goldenberg, A., Riccardi, F., Tessier, A., Pfundt, R., Busa, T., Cacciagli, P., Capri, Y., Coutton, C., Delahaye-Duriez, A., Frebourg, T., Gatinois, V., Guerrot, A.-M., Genevieve, D., Lecoquierre, F., Jacquette, A., Van Kien, P. K., Leheup, B., Marlin, S., Verloes, A., … Philip, N. (2016). Clinical and molecular findings in 39 patients with KBG syndrome caused by deletion or mutation of ANKRD11. American Journal Medical Genetics Part A, 170, 2847-2859.
Herrmann, J., Pallister, P. D., Tiddy, W., & Opitz, J. M. (1975). The KBG syndrome: A syndrome of short stature, characteristic facies, mental retardation, macrodontia and skeletal anomalies. Birth Defects Original Article Series, 11, 7-18.
Khalifa, M., Stein, J., Grau, L., Nelson, V., Meck, J., Aradhya, S., & Duby, J. (2013). Partial deletion of ANKRD11 results in the KBG phenotype distinct from the 16q24.3 microdeletion syndrome. American Journal Medical Genetics Part A, 161, 835-840.
Livak, K. J., & Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Method, 25, 402-408.
Low, K., Ashraf, T., Canham, N., Clayton-Smith, J., Deshpande, C., Donaldson, A., Fisher, R., Flinter, F., Foulds, N., Fryer, A., Gibson, K., Hayes, I., Hills, A., Holder, S., Irving, M., Joss, S., Kivuva, E., Lachlan, K., Magee, A., … Smithson, S. (2016). Clinical and genetic aspects of KBG syndrome. American Journal Medical Genetics Part A, 170, 2835-2846.
Miyatake, S., Murakami, A., Okamoto, N., Sakamoto, M., Miyake, N., Saitsu, H., & Matsumoto, N. (2013). A de novo deletion at 16q24.3 involving ANKRD11 in a Japanese patient with KBG syndrome. American Journal Medical Genetics Part A, 161, 1073-1077.
Miyatake, S., Okamoto, N., Stark, Z., Nabetani, M., Tsurusaki, Y., Nakashima, M., Miyake, N., Mizuguchi, T., Ohtake, A., Saitsu, H., & Matsumoto, N. (2017). ANKRD11 variants cause variable clinical features associated wirth KBG syndrome and Coffin-Siris-like syndrome. Journal of Human Genetics, 62, 741-746.
Morghen, I., & Ferri, E. (2008). The KBG syndrome: Case report. Cases Journal, 26, 186.
Murray, N., Burgess, B., Hay, R., Colley, A., Rajagopalan, S., McGaughran, J., Patel, C., Enriquez, A., Goodwin, L., Stark, Z., Tan, T., Wilson, M., Roscioli, T., Tekin, M., & Goel, H. (2017). KBG syndrome: An Australian experience. American Journal Medical Genetics Part A, 173, 1866-1877.
Nicolini, F., Beghi, C., & Gherli, T. J. (2009). Aortic valve regurgitation in a patient affected by KBG syndrome. Heart Valve Disease, 18, 122-124.
Novara, F., Rinaldi, B., Sisodiya, S. M., Coppola, A., Giglio, S., Stanzial, F., Benedicenti, F., Donaldson, A., Andrieux, J., Stapleton, R., Weber, A., Reho, P., van Ravenswaaij-Arts, C., Kerstjens-Frederikse, W. S., Vermeesch, J. R., Devriendt, K., Bacino, C. A., Delahaye, A., Maas, S. M., … Zuffardi, O. (2017). Haploinsufficiency for ANKRD11-flanking genes makes the difference between KBG and 16q24.3 microdeletion syndromes: 12 new cases. European Journal Human Genetics, 25, 694-701.
Ockeloen, C. W., Willemsen, M. H., de Munnik, S., van Bon, B. W., de Leeuw, N., Verrips, A., Kant, S. G., Jones, E. A., Brunner, H. G., van Loon, R. L. E., Smeets, E. E. J., van Haelst, M. M., van Haaften, G., Nordgren, A., Malmgren, H., Grigelioniene, G., Vermeer, S., Louro, P., Ramos, L., … Kleefstra, T. (2015). Further delineation of the KBG syndrome phenotype caused by ANKRD11 aberrations. European Journal Human Genetics, 23, 1176-1185.
Reuter, M. S., Chaturvedi, R. R., Liston, E., Manshaei, R., Aul, R. B., Bowdin, S., Cohn, I., Curtis, M., Dhir, P., Hayeems, R. Z., Hosseini, S. M., Khan, R., Ly, L. G., Marshall, C. R., Mertens, L., Okello, J. B. A., Pereira, S. L., Raajkumar, A., Seed, M., … Jobling, R. K. (2020). The cardiac genome clinic: Implementing genome sequencing in pediatric heart disease. Genetics in Medicine, 22, 1015-1024.
Reynaert, N., Ockeloen, C. W., Sävendahl, L., Beckers, D., Devriendt, K., Kleefstra, T., Carels, C. E., Grigelioniene, G., Nordgren, A., Francois, I., de Zegher, F., & Casteels, K. (2015). Short stature in KBG syndrome: First responses to growth hormone treatment. Hormone Research Paediatrics, 83, 361-364.
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., Voelkerding, K., Rehm, H. L., Rehm, H. L., & ACMG Laboratory Quality Assurance Committee. (2015). ACMG laboratory quality assurance committee. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine, 17, 405-424.
Rivera-Vega, M. R., Leyva Juarez, N., Cuevas-Covarrubias, S. A., & Kofman-Alfaro, S. H. (1996). Congenital heart defect and conductive hypoacusia in a patient with the KBG syndrome. Clinical Genetics, 50, 278-279.
Sacharow, S., Li, D., Fan, Y. S., & Tekin, M. (2012). Familial 16q24.3 microdeletion involving ANKRD11 causes a KBG-like syndrome. American Journal Medical Genetics Part A, 158, 547-552.
Scarano, E., Tassone, M., Graziano, C., Gibertoni, D., Tamburino, F., Perri, A., Gnazzo, M., Severi, G., & Mazzanti, L. (2019). Novel mutations and unreported clinical features in KBG syndrome. Molecular Syndromology, 10, 130-138.
Sifrim, A., Hitz, M.-P., Wilsdon, A., Breckpot, J., Al Turki, S. H., Thienpont, B., McRae, J., Fitzgerald, T. W., Singh, T., Swaminathan, G. J., Prigmore, E., Rajan, D., Abdul-Khaliq, H., Banka, S., Bauer, U. M. M., Bentham, J., Berger, F., Bhattacharya, S., Bu'Lock, F., … Hurles, M. E. (2016). Distinct genetic architectures for syndromic and nonsyndromic congenital heart defects identified by exome sequencing. Nature Genetics, 48, 1060-1065.
Sirmaci, A., Spiliopoulos, M., Brancati, F., Powell, E., Duman, D., Abrams, A., Bademci, G., Agolini, E., Guo, S., Konuk, B., Kavaz, A., Blanton, S., Digilio, M. C., Dallapiccola, B., Young, J., Zuchner, S., & Tekin, M. (2011). Mutations in ANKRD11 cause KBG syndrome, characterized by intellectual disability, skeletal malformations, and macrodontia. American Journal Human Genetics, 89, 289-294.
Willemsen, M. H., Fernandez, B. A., Bacino, C. A., Gerkes, E., de Brouwer, A. P., Pfundt, R., Sikkema-Raddatz, B., Scherer, S. W., Marshall, C. R., Potocki, L., van Bokhoven, H., & Kleefstra, T. (2010). Identification of ANKRD11 and ZNF778 as candidate genes for autism and variable cognitive impairment in the novel 16q24.3 microdeletion syndrome. European Journal Human Genetics, 18, 429-435.

Auteurs

Maria Cristina Digilio (MC)

Medical Genetics Unit and Medical Genetics and Rare Disease Research Division, Pediatric Cardiology, Medical Genetics Laboratory, Neuropsychiatry, Scientific Rectorate, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.

Giulio Calcagni (G)

Medical Genetics Unit and Medical Genetics and Rare Disease Research Division, Pediatric Cardiology, Medical Genetics Laboratory, Neuropsychiatry, Scientific Rectorate, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.

Maria Gnazzo (M)

Medical Genetics Unit and Medical Genetics and Rare Disease Research Division, Pediatric Cardiology, Medical Genetics Laboratory, Neuropsychiatry, Scientific Rectorate, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.

Paolo Versacci (P)

Pediatric Cardiology Unit, Department of Pediatrics and Urologic Sciences, "La Sapienza" University, Rome, Italy.

Maria Lisa Dentici (ML)

Medical Genetics Unit and Medical Genetics and Rare Disease Research Division, Pediatric Cardiology, Medical Genetics Laboratory, Neuropsychiatry, Scientific Rectorate, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.

Rossella Capolino (R)

Medical Genetics Unit and Medical Genetics and Rare Disease Research Division, Pediatric Cardiology, Medical Genetics Laboratory, Neuropsychiatry, Scientific Rectorate, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.

Lorenzo Sinibaldi (L)

Medical Genetics Unit and Medical Genetics and Rare Disease Research Division, Pediatric Cardiology, Medical Genetics Laboratory, Neuropsychiatry, Scientific Rectorate, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.

Anwar Baban (A)

Medical Genetics Unit and Medical Genetics and Rare Disease Research Division, Pediatric Cardiology, Medical Genetics Laboratory, Neuropsychiatry, Scientific Rectorate, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.

Carolina Putotto (C)

Pediatric Cardiology Unit, Department of Pediatrics and Urologic Sciences, "La Sapienza" University, Rome, Italy.

Paolo Alfieri (P)

Medical Genetics Unit and Medical Genetics and Rare Disease Research Division, Pediatric Cardiology, Medical Genetics Laboratory, Neuropsychiatry, Scientific Rectorate, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.

Marta Unolt (M)

Medical Genetics Unit and Medical Genetics and Rare Disease Research Division, Pediatric Cardiology, Medical Genetics Laboratory, Neuropsychiatry, Scientific Rectorate, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.

Francesca R Lepri (FR)

Medical Genetics Unit and Medical Genetics and Rare Disease Research Division, Pediatric Cardiology, Medical Genetics Laboratory, Neuropsychiatry, Scientific Rectorate, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.

Viola Alesi (V)

Medical Genetics Unit and Medical Genetics and Rare Disease Research Division, Pediatric Cardiology, Medical Genetics Laboratory, Neuropsychiatry, Scientific Rectorate, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.

Silvia Genovese (S)

Medical Genetics Unit and Medical Genetics and Rare Disease Research Division, Pediatric Cardiology, Medical Genetics Laboratory, Neuropsychiatry, Scientific Rectorate, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.

Antonio Novelli (A)

Medical Genetics Unit and Medical Genetics and Rare Disease Research Division, Pediatric Cardiology, Medical Genetics Laboratory, Neuropsychiatry, Scientific Rectorate, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.

Bruno Marino (B)

Pediatric Cardiology Unit, Department of Pediatrics and Urologic Sciences, "La Sapienza" University, Rome, Italy.

Bruno Dallapiccola (B)

Medical Genetics Unit and Medical Genetics and Rare Disease Research Division, Pediatric Cardiology, Medical Genetics Laboratory, Neuropsychiatry, Scientific Rectorate, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH